Decoding the Role of Antimicrobial Peptides in the Fight against Mycobacterium tuberculosis
Authors:
- 28 January 2025
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (2) , 350-365
Abstract
Tuberculosis (TB), a leading infectious disease caused by the pathogen Mycobacterium tuberculosis, poses a significant treatment challenge due to its unique characteristics and resistance to existing drugs. The conventional treatment regimens, which are lengthy and involve multiple drugs, often result in poor patient adherence and subsequent drug resistance, particularly with multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. This highlights the urgent need for novel anti-TB therapies and new drug targets. Antimicrobial peptides (AMPs), which are natural host defense molecules present in all living organisms, offer a promising alternative to traditional small-molecule drugs. AMPs have several advantages, including their broad-spectrum activity and the potential to circumvent existing resistance mechanisms. However, their clinical application faces challenges such as stability, delivery, and potential toxicity. This review aims to provide essential information on AMPs, including their sources, classification, mode of action, induction within the host under stress, efficacy against M. tuberculosis, clinical status and hurdles to their use. It also highlights future research directions to address these challenges and advance the development of AMP-based therapies for TB.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (CSPS24/RDSF/IIIM/IHP24/07)
- University Grants Commission
- Anusandhan National Research Foundation (SRG/2022/001567)
- Central Council for Research in Ayurvedic Sciences (GAP-3144)
This publication has 105 references indexed in Scilit:
- Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trialArchives of Dermatological Research, 2023
- Role of Antimicrobial Peptides in Treatment and Prevention of Mycobacterium Tuberculosis: A ReviewInternational Journal of Peptide Research and Therapeutics, 2022
- Delivery by Dendritic Mesoporous Silica Nanoparticles Enhances the Antimicrobial Activity of a Napsin‐Derived Peptide Against Intracellular Mycobacterium tuberculosisAdvanced Healthcare Materials, 2021
- Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistanceCellular and Molecular Life Sciences, 2021
- Cysteine‐rich antimicrobial peptides from plants: The future of antimicrobial therapyPhytotherapy Research, 2020
- Antimicrobial Peptides (AMPs): Roles, Functions and Mechanism of ActionInternational Journal of Peptide Research and Therapeutics, 2019
- Antimicrobial peptides: Promising alternatives in the post feeding antibiotic eraMedicinal Research Reviews, 2018
- Peptide design for antimicrobial and immunomodulatory applicationsPeptide Science, 2013
- Antimicrobial Efflux Pumps and Mycobacterium tuberculosis Drug Tolerance: Evolutionary Considerations2012
- Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides2006